Latar Belakang. Pemberian obat anti epilepsi (OAE) generasi pertama dalam jangka waktu lama sering menimbulkan efek samping seperti perubahan kadar lipid plasma yang akan meningkatkan resiko penyakit kardiovaskular dan serebrovaskular. OAE ini banyak digunakan di poli neurologi RSCM. Diharapkan dengan diketahuinya gambaran kadar lipid plasma pada penggunaan OAE generasi pertama tunggal dan prevalensi dislipidemia, dapat dilakukan penapisan dini dan preventif timbulnya penyakit kardio dan serebrovaskular. Metode. Desain penelitian berupa studi potong lintang (cross sectional). Subyek penelitian adalah orang dengan epilepsi yang mendapat karbamazepin, fenitoin, fenobarbital dan valproat tunggal minimal 6 bulan. Subyek diperoleh secara konsekutif, kemudian dilakukan wawancara data medis, recall makanan, pemeriksaan fisik dan kadar lipid darah. Pemeriksaan kadar lipid dilakukan setelah puasa minimal 8 jam. Hasil. Diperoleh 59 subyek, 27 karbamazepin, 16 fenitoin, 10 fenobarbital dan 6 valproat. Prevalensi dislipidemia sebesar 20.3%. Rerata kadar kolesterol total 193.5 ± 31.9; LDL 115.3 ± 23.9; HDL 59.5 ± 18.8 dan trigliserida 117.0 ± 63.6. Rerata kadar kolesterol total, LDL dan trigliserida fenitoin lebih tinggi dari OAE lain. Rerata HDL terendah ditemukan pada valproat. Didapat perbedaan bermakna secara statistik rerata kolesterol total, LDL dan trigliseria berdasarkan jenis OAE. Didapat hubungan bermakna secara stastistik antara durasi penggunaan OAE dengan tingginya kadar HDL pada karbamazepin dan fenobabital. Kesimpulan. Rerata kadar lipid dibawah rerata kadar lipid populasi. Dislipidemia lebih banyak ditemukan pada kelompok fenitoin. Durasi penggunaan OAE berhubungan dengan kadar HDL tinggi.

---

Background. Longterm therapy with first generation of antiepileptic drugs (AED) has been associated with adverse effects, such as serum lipid profile changes which can increase the risk of cardiovaskular and cerebrovascular disease. These AEDs are commonly used in outpatient clinic at Cipto Mangunkusumo hospital. The aim of this study is knowing lipid profile in first generation AEDs consumption.

Method. This was cross sectional study. The subjects of this study were epilepsy patiets receiving carbamazepine, phenytoin, phenobarbital and valproate as monotheraphy for more than 6 months. This study used concecutive sampling. All subjects were interviewed, food recalled and underwent physical examination and measurements serum lipid profile. Blood samples for serum lipid profile were collected at least after 8 hours overnight fasting.

Result. There were 59 patients, 27 with carbamazepine therapy, 16 phenytoin, 10 phenobarbital, 6 valproate. Prevalence of dyslipidemia is 20.3%. Mean of total cholesterol is 193.5 ± 31.9; LDL 115.3 ± 23.9; HDL 59.5 ± 18.8 and triglyseride 117.0 ± 63.6. Patients with phenytoin showed the highest mean of total cholesterol, LDL and triglyseride. Patients with valpoate showed the lowest mean of HDL. There was significant difference in mean of cholesterol total, LDL and triglyseride according to AEDs. The duration of AEDs therapy was significantly associated with higher HDL in patents with carbamazepine and Phenobarbital.

Conclusion. Mean of lipid profile among people with epilepsy was lower than population. Dyslipidemia were more frequent in phenytoin. The duration of AEDs therapy was significantly associated with higher HDL.